Business Disposal: GSK Dumps Affymax

London-Following a review of its own drug discovery capabilities, GlaxoSmithKline practically gave away its majority stake in Affymax to a group of venture capitalists led by Patricof.

Related Content:

Pharmaceutical Executive-09-01-2001

Profits and Promotion Under Attack

Church and State

Document Leak: NICE Says No to MS